Results 51 to 60 of about 18,425 (234)

Recent advances in self-targeting natural product-based nanomedicines

open access: yesJournal of Nanobiotechnology
Natural products, recognized for their potential in disease prevention and treatment, have been integrated with advanced nano-delivery systems to create natural product-based nanomedicines, offering innovative approaches for various diseases.
Haifan Liu   +11 more
doaj   +1 more source

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Healthy volunteers (HVs) are essential for phase I trials, yet their recruitment and screening remain resource‐intensive and ethically complex. High screening failure (SF) rates highlight the need to evaluate and understand all aspects of the enrolment processes. We analyzed SF patterns in a large German HV cohort and explored participants' motivations,
Evelyn Krohmer   +10 more
wiley   +1 more source

Bioequivalence of losartan/amlodipine fixed dose combination tablets (losanet AM) compared with concomitant administration of Single components of losartan and amlodipine tablets in healthy human volunteers [PDF]

open access: yes, 2017
A fixed dose combination of losartan, an angiotensin receptor blocker and amlodipine, a calcium channel blocker, can potentially provide complementary mechanism of action to improve blood pressure control and clinical outcomes.
Daccache, Elie   +7 more
core   +1 more source

The EMA Qualification Opinion for CYP Inhibition‐Mediated Drug–Drug Interaction Predictions: Implications for PBPK Credibility Assessment in the Era of ICH M15

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Clinical pharmacology and pharmacometrics teams are now being encouraged to implement the ICH M15 framework in drug development to support model‐informed decisions in regulatory submissions. Although model performance is an important component of model evaluation, regulatory confidence also depends on the intended context of use (CoU) and the ...
Karen Rowland Yeo   +6 more
wiley   +1 more source

Elaboration of technology and comparative research of pellets of tamsulosin the modified liberation

open access: yesБюллетень сибирской медицины, 2011
The work purpose consisted in elaboration of technology of reception pellets of tamsulosin with the modified liberation, and also an estimation of their comparative bioequivalence with a comparison preparation.
Ye. V. Blynskaya   +3 more
doaj   +1 more source

Green Tea Extract Decreases the Systemic Exposure of Pazopanib in Healthy Participants

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Green tea catechins modulate the activity of key drug pharmacokinetic determinants and consequently, concomitant consumption of green tea can significantly alter systemic drug exposure. This study aimed to investigate the influence of concomitant green tea catechin consumption on the pharmacokinetics of pazopanib, a tyrosine kinase inhibitor used in ...
Nicki M. Kyriacou   +4 more
wiley   +1 more source

Generative Neural Networks for Addressing the Bioequivalence of Highly Variable Drugs

open access: yesAlgorithms
Bioequivalence assessment of highly variable drugs (HVDs) remains a significant challenge, as the application of scaled approaches requires replicate designs, complex statistical analyses, and varies between regulatory authorities (e.g., FDA and EMA ...
Anastasios Nikolopoulos   +1 more
doaj   +1 more source

The effect of antiseizure medications on the exposure to combined oral contraceptives: A systematic review and network meta‐analysis

open access: yesEpileptic Disorders, EarlyView.
Abstract Objective Current recommendations for prescribing combined oral contraceptives (COCs) to people with epilepsy are often conflicting, particularly for weak inducers of cytochrome P450 3A4. We aimed to critically review the literature and compare the antiseizure medication (ASM)‐induced changes in exposure to COC components.
Hagar Cohen   +4 more
wiley   +1 more source

Semiparametric Bayesian Modeling of Multivariate Average Bioequivalence [PDF]

open access: yes, 2006
Bioequivalence trials are usually conducted to compare two or more formulations of a drug. Simultaneous assessment of bioequivalence on multiple endpoints is called multivariate bioequivalence.
Ghosh, Pulak, Dr., Gonen, Mithat
core   +1 more source

Generic drugs: myths, facts, and limitations

open access: yesItalian Journal of Medicine, 2012
Bioequivalence (BE) has always been an important pharmaceutical area, particularly (but not solely) in Mediterranean region, where the use of generic drugs is a relatively recent development. The lack of new therapeutic molecules has concentrated primary
Antonio Marzo   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy